Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung Cancer

The prognostic landscape of genes and infiltrating immune cells across human cancers

(2015) Andrew J Gentles et al.   NATURE MEDICINE

Drug Index

(2014)   Journal of Thoracic Oncology

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†

(2013) H. A. Azim et al.   ANNALS OF ONCOLOGY

Gene expression profiling in breast cancer: A clinical perspective

(2013) Grazia Arpino et al.   BREAST

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients

(2013) H. Tang et al.   CLINICAL CANCER RESEARCH

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

(2013) I. I. Wistuba et al.   CLINICAL CANCER RESEARCH

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

(2013) Juan Sandoval et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry

(2013) Bing-Yen Wang et al.   Journal of Thoracic Oncology

Criteria for the use of omics-based predictors in clinical trials

(2013) Lisa M. McShane et al.   NATURE

Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

(2013) S. Rousseaux et al.   Science Translational Medicine

Human housekeeping genes, revisited

(2013) Eli Eisenberg et al.   TRENDS IN GENETICS

Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival

(2012) Nancy Lan Guo et al.   ARTIFICIAL INTELLIGENCE IN MEDICINE

Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort

(2012) Amy K. Ferketich et al.   CANCER

The Role of Genetic Markers in the Management of Prostate Cancer

(2012) Atish D. Choudhury et al.   EUROPEAN UROLOGY

A lung cancer molecular prognostic test ready for prime time

(2012) Yang Xie et al.   LANCET

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

(2012) Johannes R Kratz et al.   LANCET

Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma

(2012) Tatsuya Kato et al.   LUNG CANCER

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma

(2012) Yun-Yong Park et al.   PLoS One

Non–Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results

(2012) Olivier Gevaert et al.   RADIOLOGY

A 10-Gene Progenitor Cell Signature Predicts Poor Prognosis in Lung Adenocarcinoma

(2011) Mark Onaitis et al.   ANNALS OF THORACIC SURGERY

Circulating Tumor Cells and Circulating Tumor DNA

(2011) Catherine Alix-Panabières et al.   Annual Review of Medicine

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

(2011) A. A. Alizadeh et al.   BLOOD

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

(2011) Richard D. Kennedy et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

(2011) Richard G. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer

(2011) Zachary D. Horne et al.   JOURNAL OF SURGICAL RESEARCH

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system

(2011) Shamus R. Carr et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Development and Validation of a Quantitative Real-Time Polymerase Chain Reaction Classifier for Lung Cancer Prognosis

(2011) Guoan Chen et al.   Journal of Thoracic Oncology

AutoSOME: a clustering method for identifying gene expression modules without prior knowledge of cluster number

(2010) Aaron M Newman et al.   BMC BIOINFORMATICS

Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study

(2010) Jens Neumann et al.   BMC CANCER

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

(2010) Humam Kadara et al.   CLINICAL CANCER RESEARCH

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer

(2010) Chang-Qi Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?

(2010) J. Subramanian et al.   JNCI-Journal of the National Cancer Institute

Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project

(2010) Marianne Paesmans et al.   Journal of Thoracic Oncology

What should physicians look for in evaluating prognostic gene-expression signatures?

(2010) Jyothi Subramanian et al.   Nature Reviews Clinical Oncology

Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions

(2010) R. Sangha et al.   ONCOLOGIST

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer

(2009) Boone Goodgame et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis

(2009) Shuta Tomida et al.   JOURNAL OF CLINICAL ONCOLOGY

Basal cells as stem cells of the mouse trachea and human airway epithelium

(2009) J. R. Rock et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells

(2008) David J. Wong et al.   Cell Stem Cell

A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma

(2008) D. J. Raz et al.   CLINICAL CANCER RESEARCH

Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

(2008) E.-S. Lee et al.   CLINICAL CANCER RESEARCH

Confirmation of Gene Expression-Based Prediction of Survival in Non-Small Cell Lung Cancer

(2008) N. L. Guo et al.   CLINICAL CANCER RESEARCH

An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer

(2008) P. Roepman et al.   CLINICAL CANCER RESEARCH

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer

(2008) Yasumitsu Moriya et al.   LUNG CANCER

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

(2008) Kerby Shedden et al.   NATURE MEDICINE